Patents by Inventor Ibraheem T. Badejo

Ibraheem T. Badejo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190076140
    Abstract: A method of reinforcing subcutaneous fragile tissue includes obtaining an absorbable surgical mesh having top and bottom major surfaces, the absorbable surgical mesh including a stitching zone and first and second reinforcing zones that bound opposite sides of the stitching zone. The method includes making an incision in a patient's skin for exposing subcutaneous fragile tissue, using one or more absorbable adhesives for adhering the bottom major surface of the absorbable surgical mesh to the subcutaneous fragile tissue, creating an incision through the stitching zone of the absorbable surgical mesh and into the subcutaneous fragile tissue, performing a surgical procedure through the incision, and passing an absorbable suture through the stitching zone of the absorbable surgical mesh and the fragile tissue for closing the incision.
    Type: Application
    Filed: September 13, 2017
    Publication date: March 14, 2019
    Inventors: Julian Quintero, Leo B. Kriksunov, Shane A. Lacy, Ibraheem T. Badejo
  • Patent number: 8153743
    Abstract: An adhesive composition includes one or more polymerizable cyanoacrylate monomers, a polymerization initiator and a polymerization accelerator for the one or more polymerizable cyanoacrylate monomers. A system for treating living tissue includes a first reservoir containing one or more polymerizable cyanoacrylate monomers, a second reservoir in a non-contacting relationship with the first reservoir containing a polymerization initiator and accelerator for the one or more polymerizable cyanoacrylate monomers, and an applicator capable of combining the polymerizable cyanoacrylate monomer and the polymerization initiator and accelerator to form an adhesive composition and then applying the adhesive composition to living tissue. The initiator may be a quaternary ammonium salt, and the accelerator may be a trihydroxy tertiary amine.
    Type: Grant
    Filed: July 31, 2008
    Date of Patent: April 10, 2012
    Assignee: Closure Medical Corporation
    Inventors: Ibraheem T. Badejo, Andres Rivera, Melanie Vander Klok
  • Patent number: 7932305
    Abstract: A polymerizable adhesive composition comprises at least one ?-cyanoacrylate monomer and at least one absorbable viscosity modifying agent. The absorbable viscosity modifying agent has repeated units of the following structure: R1 is a methyl group or a hydrogen. R2 is a straight, branched or cyclic alkyl group having from 1 to 6 carbon atoms. R3 is a straight, branched or cyclic alkyl group having from 1 to 12 carbon atoms, and n is 2 or more.
    Type: Grant
    Filed: June 27, 2008
    Date of Patent: April 26, 2011
    Assignee: Ethicon, Inc.
    Inventors: Ibraheem T. Badejo, Teresa Marie Warren, Brian McCrum
  • Publication number: 20100269749
    Abstract: An adhesive composition is provided including one or more polymerizable cyanoacrylate monomers and boron trifluoride as a stabilizer or complexing agent. The adhesive composition may also include or be used with a decomplexing agent, particularly one or more quaternary ammonium fluoride salts or one or more quaternary ammonium ether salts. A polymerization initiator or accelerator may also be used. The viscosity of the adhesive composition may be controlled by addition of a thickening agent which may be a polymer or copolymer catalyzed by a boron trifluoride complex or compound. Methods for the application of the adhesive compositions to living tissue are also provided.
    Type: Application
    Filed: July 9, 2010
    Publication date: October 28, 2010
    Inventors: Ibraheem T. Badejo, Teresa Warren
  • Publication number: 20100030258
    Abstract: An adhesive composition includes one or more polymerizable cyanoacrylate monomers, a polymerization initiator and a polymerization accelerator for the one or more polymerizable cyanoacrylate monomers. A system for treating living tissue includes a first reservoir containing one or more polymerizable cyanoacrylate monomers, a second reservoir in a non-contacting relationship with the first reservoir containing a polymerization initiator and accelerator for the one or more polymerizable cyanoacrylate monomers, and an applicator capable of combining the polymerizable cyanoacrylate monomer and the polymerization initiator and accelerator to form an adhesive composition and then applying the adhesive composition to living tissue. The initiator may be a quaternary ammonium salt, and the accelerator may be a trihydroxy tertiary amine.
    Type: Application
    Filed: July 31, 2008
    Publication date: February 4, 2010
    Inventors: Ibraheem T. BADEJO, Andres RIVERA, Melanie VANDER KLOK
  • Publication number: 20090326095
    Abstract: A polymerizable adhesive composition comprises at least one ?-cyanoacrylate monomer and at least one absorbable viscosity modifying agent. The absorbable viscosity modifying agent has repeated units of the following structure: R1 is a methyl group or a hydrogen. R2 is a straight, branched or cyclic alkyl group having from 1 to 6 carbon atoms. R3 is a straight, branched or cyclic alkyl group having from 1 to 12 carbon atoms, and n is 2 or more.
    Type: Application
    Filed: June 27, 2008
    Publication date: December 31, 2009
    Inventors: Ibraheem T. BADEJO, Teresa Marie WARREN, Brian McCRUM
  • Patent number: 7318937
    Abstract: Liquid coating compositions are provided that comprise siloxane containing polymer, volatile polydimethylsiloxane, and aliphatic hydrocarbon. The liquid coating compositions preferably comprise from 18-55 weight % of volatile polydimethylsiloxane, from 5-55 weight % of aliphatic hydrocarbon, from 1-40 weight % of siloxane containing polymer, and from 0-15 weight % of adjuvant.
    Type: Grant
    Filed: March 18, 2005
    Date of Patent: January 15, 2008
    Assignee: Closure Medical Corporation
    Inventors: Jerry Y. Jonn, Brian McCrum, Wendy Su, Teresa Warren, Ibraheem T. Badejo
  • Publication number: 20080003196
    Abstract: An adhesive composition is provided including one or more polymerizable cyanoacrylate monomers and boron trifluoride as a stabilizer or complexing agent. The adhesive composition may also include or be used with a decomplexing agent, particularly one or more quaternary ammonium fluoride salts or one or more quaternary ammonium ether salts. A polymerization initiator or accelerator may also be used. The viscosity of the adhesive composition may be controlled by addition of a thickening agent which may be a polymer or copolymer catalyzed by a boron trifluoride complex or compound. Methods for the application of the adhesive compositions to living tissue are also provided.
    Type: Application
    Filed: June 30, 2006
    Publication date: January 3, 2008
    Inventors: Jerry Y. Jonn, Ibraheem T. Badejo, Julian A. Quintero, Teresa Warren, Melanie A. Vander Klok
  • Publication number: 20070185229
    Abstract: A cyanoacrylate monomer is used as an adhesion-enhancement material for enhancing at least an initial bond between a person's skin and a hydrocolloid adhesive of e.g., an ostomy or wound care appliance, for attachment to the skin. The monomer is applied to the skin in a non-activated state. Polymerization of the momoner is initiated by a material in the hydrocolloid adhesive when the adhesive appliance is pressed on the skin thereafter. The adhesion-enhancement material may further comprise a plasticizer having a low Tg (e.g., <10° C.).
    Type: Application
    Filed: February 1, 2007
    Publication date: August 9, 2007
    Applicant: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: Ibraheem T. Badejo, Kenneth A. Johnsen, John B. Cline
  • Patent number: 6607631
    Abstract: A polymerizable monomer adhesive composition includes a 1,1-disubstituted ethylene monomer and at least one slip additive, where the slip additive causes a polymer film formed from the monomer to have a lower coefficient of friction than in an absence of the slip additive. The slip additive can be selected from, inter alia, fluorinated monomers or polymers, fluorinated additives, siloxane-containing monomers or polymers, siloxane-containing additives, fluorinated siloxanes, and long chain fatty acid esters. The slip additive can also form a second phase in a resultant polymer film, where the second phase is soluble in the monomer but is insoluble or substantially insoluble in the polymer.
    Type: Grant
    Filed: September 8, 2000
    Date of Patent: August 19, 2003
    Assignee: Closure Medical Corporation
    Inventors: Ibraheem T. Badejo, Wendy Y. Su, Keith R. D'Alessio, Jerry Jonn, Julian A. Quintero, Michelle Knotts, Timothy P. Hickey, Lawrence H. Mainwaring, Upvan Narang
  • Patent number: 6605667
    Abstract: An adhesive composition includes a polymerizable adhesive monomer and at least one antioxidant stabilizer, and/or a container for storing said monomer composition that includes an antioxidant stabilizer. The antioxidant stabilizer provides superior stabilization and shelf-life of the composition and/or the container, and may enhance wound healing properties of the monomer composition.
    Type: Grant
    Filed: September 8, 2000
    Date of Patent: August 12, 2003
    Assignee: Closure Medical Corporation
    Inventors: Ibraheem T. Badejo, Jaime Ayarza, Anthony Voiers, Roy F. Thompson, Jr., Gabriel N. Szabo, Robert V. Toni, William S. C. Nicholson
  • Patent number: 6595940
    Abstract: A disposable applicator includes a generally tubular applicator body having a closed proximal end and an open distal end and a frangible vial inside. The proximal end is covered by a drying swab while the distal end is covered by an applicator swab that is in open communication with the interior of the applicator body. Within the applicator body is a frangible vial containing a biomedically useful liquid composition, such as an &agr;-cyanoacrylate adhesive, a medicament, or both. The applicator is useful for applying liquid compositions to target sites such as tissue, particularly sites of topical pathology, such as stomatitis lesions.
    Type: Grant
    Filed: October 29, 1999
    Date of Patent: July 22, 2003
    Assignee: Closure Medical Corporation
    Inventors: Keith R. D'Alessio, William M. Cotter, Upvan Narang, Lawrence H. Mainwaring, Ibraheem T. Badejo, Daniel L. Hedgpeth, Gabriel N. Szabo, Anthony Sherbondy, Joe B. Barefoot
  • Patent number: 6579469
    Abstract: An adhesive composition that contains a preservative is particularly useful as a medical adhesive and can include alkyl cyanoacrylate monomers. The preservative is preferably soluble in the monomer. The composition may optionally be sterilized by placing a mixture of a polymerizable adhesive monomer and a preservative in a container, sealing the container, and sterilizing the mixture and the container.
    Type: Grant
    Filed: October 29, 1999
    Date of Patent: June 17, 2003
    Assignee: Closure Medical Corporation
    Inventors: William S. C. Nicholson, Upvan Narang, Ubonwan A. Stewart, Daniel L. Hedgpeth, Ibraheem T. Badejo, Lawrence H. Mainwaring
  • Publication number: 20030060380
    Abstract: An adhesive remover composition and methods for removing medical grade and other adhesive compositions including, but not limited to, cyanoacrylate adhesive compositions from surfaces including, but not limited to, areas of tissue, including areas of compromised skin. The composition, which is preferably bio-compatible, includes a suitable remover compound such as an alkylester plasticizer combined with an antimicrobial preservative to protect the composition from microorganisms. A method of removing adhesive compositions includes applying the remover composition to the adhesive composition using an applicator, such as a spray applicator or a towelette, allowing the remover to interact with the adhesive composition and then removing the remover and the adhesive composition.
    Type: Application
    Filed: September 26, 2001
    Publication date: March 27, 2003
    Applicant: Closure Medical Corporation
    Inventors: Jaime Ayarza, Ibraheem T. Badejo, Joe B. Barefoot, Daniel L. Hedgpeth, Michelle M. Knotts, Bernard Malofsky, Upvan Narang, Gina L. Spath, Wendy Y. Su
  • Publication number: 20030039781
    Abstract: A combination includes a pipette-shaped container formed from a polymeric material selected from polyethylene terephthalate, high density polyethylene, low density polyethylene, and mixtures thereof, and a 1,1 -disubstituted ethylene monomer adhesive composition sealed in the pipette-shaped container prior to dispensing the material.
    Type: Application
    Filed: September 13, 2002
    Publication date: February 27, 2003
    Applicant: Closure Medical Corporation
    Inventors: Keith R. D'Alessio, Andres Rivera, William M. Cotter, Ibraheem T. Badejo
  • Publication number: 20030032833
    Abstract: Continuous processes for forming cyanoacrylate from polycyanoacrylate include stripping a solvent from a reaction mass; cracking a polymer in the reaction mass to form a cracked cyanoacrylate monomer and residue substances; and distilling the cracked cyanoacrylate monomer to produce a cyanoacrylate monomer product. These steps can be performed in short-path, wiped-film evaporators. Polycyanoacrylate used in the processes can be formed using cyanoacetate produced by processes for continuously producing cyanoacetate by forming a higher homologue cyanoacetate from a lower homologue cyanoacetate. The cyanoacetate can be formed in short-path, wiped-film evaporators.
    Type: Application
    Filed: May 16, 2002
    Publication date: February 13, 2003
    Applicant: Closure Medical Corporation
    Inventors: Ibraheem T. Badejo, Jaime Ayarza, Kenneth W. Davis, Jeffrey R. Hennenkamp
  • Patent number: 6494948
    Abstract: This invention relates to a process for preparing quinacridone pigment compositions by (a) heating a reaction mixture containing (i) 2,5-dianilinoterephthalic acid or 2,5-dianilino-6,13-dihydroterephthalic acid or a derivative thereof, (ii) about 0.1 to about 5 percent, based on component (a)(i), of 2,5-di(sulfamoylanilino)terephthalic acid and/or 2,5-di(sulfamoylanilino)-6,13-dihydroterephthalic acid or a derivative thereof, (iii) about 0.1 to about 15 percent by weight, based on component (a)(i), of other sulfonyl-containing derivatives of 2,5-dianilinoterephthalic acid and/or 2,5-dianilino-6,13-dihydroterephthalic acid, (iv) about 3 to about 20 parts by weight, per part of component (a)(i), of a dehydrating agent, and (v) optionally, a solvent; (b) drowning the reaction mixture from step (a) with a liquid in which the quinacridone pigment composition is substantially insoluble; and (c) isolating the quinacridone pigment composition.
    Type: Grant
    Filed: December 22, 2000
    Date of Patent: December 17, 2002
    Assignee: Bayer Corporation
    Inventors: Daphne J. Rice, Ibraheem T. Badejo
  • Patent number: 6455064
    Abstract: A composition comprising a polymerizable adhesive monomer is applied over a biologically active initiator or accelerator for polymerization of the monomer. The biologically active initiator or accelerator is a medicament that provides a desired medical or therapeutic activity as well as enhancing polymerization of the adhesive.
    Type: Grant
    Filed: October 29, 1999
    Date of Patent: September 24, 2002
    Assignee: Closure Medical Corporation
    Inventors: Upvan Narang, Daniel L. Hedgpeth, Gabriel N. Szabo, Ibraheem T. Badejo, Joe B. Barefoot
  • Patent number: 6420590
    Abstract: Continuous processes for forming cyanoacrylate from polycyanoacrylate include stripping a solvent from a reaction mass; cracking a polymer in the reaction mass to form a cracked cyanoacrylate monomer and residue substances; and distilling the cracked cyanoacrylate monomer to produce a cyanoacrylate monomer product. These steps can be performed in short-path, wiped-film evaporators. Polycyanoacrylate used in the processes can be formed using cyanoacetate produced by processes for continuously producing cyanoacetate by forming a higher homologue cyanoacetate from a lower homologue cyanoacetate. The cyanoacetate can be formed in short-path, wiped-film evaporators.
    Type: Grant
    Filed: October 31, 2000
    Date of Patent: July 16, 2002
    Assignee: Closure Medical Corporation
    Inventors: Ibraheem T. Badejo, Jaime Ayarza, Kenneth W. Davis, Jeffrey R. Hennenkamp
  • Publication number: 20020078860
    Abstract: This invention relates to a process for preparing quinacridone pigment compositions by
    Type: Application
    Filed: December 22, 2000
    Publication date: June 27, 2002
    Inventors: Daphne J. Rice, Ibraheem T. Badejo